title: Treatment of primary Sjogren syndrome with rituximab: extended follow-up, safety and efficacy of retreatment.
authors.forename: J M
authors.initials: JM
authors.lastname: Meijer
authors.forename: J
authors.initials: J
authors.lastname: Pijpe
authors.forename: A
authors.initials: A
authors.lastname: Vissink
authors.forename: C G M
authors.initials: CG
authors.lastname: Kallenberg
authors.forename: H
authors.initials: H
authors.lastname: Bootsma
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D019233:Retreatment; D000069283:Rituximab; D012859:Sjogren's Syndrome / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007166:Immunosuppressive Agents; D000069283:Rituximab